DK546287A - Forbindelse til behandling af hukommelsessvigt - Google Patents

Forbindelse til behandling af hukommelsessvigt

Info

Publication number
DK546287A
DK546287A DK546287A DK546287A DK546287A DK 546287 A DK546287 A DK 546287A DK 546287 A DK546287 A DK 546287A DK 546287 A DK546287 A DK 546287A DK 546287 A DK546287 A DK 546287A
Authority
DK
Denmark
Prior art keywords
relationship
treatment
memory failure
failure
memory
Prior art date
Application number
DK546287A
Other languages
Danish (da)
English (en)
Other versions
DK546287D0 (da
Inventor
Amy F T Arnsten
Patricia S Goldman-Rakic
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of DK546287D0 publication Critical patent/DK546287D0/da
Publication of DK546287A publication Critical patent/DK546287A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK546287A 1986-11-07 1987-10-19 Forbindelse til behandling af hukommelsessvigt DK546287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/928,442 US4847300A (en) 1986-11-07 1986-11-07 Use of alpha-2I selective adrenergic receptor agonists in memory enhancement

Publications (2)

Publication Number Publication Date
DK546287D0 DK546287D0 (da) 1987-10-19
DK546287A true DK546287A (da) 1988-05-08

Family

ID=25456234

Family Applications (1)

Application Number Title Priority Date Filing Date
DK546287A DK546287A (da) 1986-11-07 1987-10-19 Forbindelse til behandling af hukommelsessvigt

Country Status (12)

Country Link
US (1) US4847300A (ko)
EP (1) EP0268912A3 (ko)
JP (1) JPS63183524A (ko)
KR (1) KR880005926A (ko)
AU (1) AU601771B2 (ko)
CA (1) CA1307741C (ko)
DK (1) DK546287A (ko)
IE (1) IE872994L (ko)
IL (1) IL84223A0 (ko)
NZ (1) NZ222464A (ko)
PH (1) PH23840A (ko)
PT (1) PT86059B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia
US5854290A (en) * 1995-09-21 1998-12-29 Amy F. T. Arnsten Use of guanfacine in the treatment of behavioral disorders
WO2006125324A1 (en) * 2005-05-27 2006-11-30 Queen's University At Kingston Treatment of protein folding disorders
US20090076156A1 (en) * 2005-07-18 2009-03-19 Masud Husain Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
FR2893844B1 (fr) * 2005-11-28 2008-02-01 Centre Nat Rech Scient Utilisation du guanabenz et de ses derives pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
US20120041068A1 (en) * 2010-08-11 2012-02-16 Aptapharma, Inc. Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE893276A (fr) * 1981-06-01 1982-11-24 Sandoz Sa Nouvelle application therapeutique d'un derive de l'acetamide
CH649918A5 (de) * 1981-07-09 1985-06-28 Sandoz Ag Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie.

Also Published As

Publication number Publication date
EP0268912A2 (en) 1988-06-01
CA1307741C (en) 1992-09-22
PT86059A (en) 1987-12-01
AU7977087A (en) 1988-05-12
EP0268912A3 (en) 1990-02-28
PT86059B (pt) 1990-07-31
JPS63183524A (ja) 1988-07-28
PH23840A (en) 1989-11-23
NZ222464A (en) 1990-08-28
DK546287D0 (da) 1987-10-19
IL84223A0 (en) 1988-03-31
US4847300A (en) 1989-07-11
IE872994L (en) 1988-05-07
AU601771B2 (en) 1990-09-20
KR880005926A (ko) 1988-07-21

Similar Documents

Publication Publication Date Title
DK618387D0 (da) Fremgangsmaade til sterilisering
DK469987A (da) Fremgangsmaade til oprensning af makromokylaere produkter.
DK93887A (da) Heterocycliske forbindelser
DK99086A (da) Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser
DK76185D0 (da) Forbedrede praeparater til behandling af psoriasis
DK530287D0 (da) Fremgangsmaade til behandling af spildevand
DK287688D0 (da) Heterocycliske forbindelser
NO870409L (no) Fremgangsmaate for spaltning av 1-aminoindaner.
DK546287A (da) Forbindelse til behandling af hukommelsessvigt
DK298187D0 (da) Applikator til behandling af laeber
DK499987D0 (da) Heterocycliske forbindelser
DK191987D0 (da) Fremgangsmaade til indstilling af ph-vaerdien af en oploesning
DK462886D0 (da) Algedraebende midler til behandling af vandsystemer
NO872255D0 (no) Fremgangsmaate for dekaffinering av raakaffe.
DK509587A (da) Fremgangsmaade til inhibering af genekspression
DK593287A (da) Fremgangsmaade til rensning af roeggas
DK625486A (da) Fremgangsmaade til rensning af roeggas
DK219885A (da) Tetrahydronaphthalenoler til behandling af hypertension
DK45887D0 (da) Heterocykliske forbindelser
DK343587D0 (da) Acylerede heterocycliske forbindelser
DK510785D0 (da) Oploesning til behandling af taender
DK157204C (da) Fremgangsmaade til stabilisering af grunde
DK130992D0 (da) Fremgangsmaade til fremstilling af angiotenxinomdannende enzyminhibitorer
DK415488D0 (da) Fremgangsmaade til behandling af jern-ii-holdige former for vand
DK302786D0 (da) Samleled til samling af langstrakte elementer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment